Revance Therapeutics Inc. (RVNC)
3.65
0.00 (0.00%)
At close: Feb 05, 2025, 3:59 PM
Revance Therapeutics Fail-to-Deliver
Total FTD Shares
1.84M
Above Average
FTD / Avg. Volume
62.35%
High Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
Over the past year, Revance Therapeutics Inc. has seen a monthly average of
30,350 fail to deliver shares.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Feb 06, 2025 | 3.65 | 1.84M | +184464900.00% |
Jan 31, 2025 | 3.63 | 1 | -99.98% |
Dec 31, 2024 | 3.06 | 6.19K | +495.96% |
Nov 12, 2024 | 3.45 | 1.04K | -41.60% |
Oct 29, 2024 | 5.90 | 1.78K | +2405.63% |
Sep 24, 2024 | 5.37 | 71 | -97.68% |
Aug 20, 2024 | 6.61 | 3.06K | +8400.00% |
Jul 31, 2024 | 3.70 | 36 | -99.77% |
Jun 28, 2024 | 2.58 | 15.74K | +11.62% |
May 30, 2024 | 2.80 | 14.1K | +405.52% |
Apr 26, 2024 | 3.29 | 2.79K | -54.58% |
Mar 27, 2024 | 4.70 | 6.14K | -92.45% |
Feb 23, 2024 | 5.31 | 81.35K | +992.37% |
Jan 31, 2024 | 5.51 | 7.45K | +744600.00% |
Dec 12, 2023 | 7.41 | 1 | -97.67% |
Nov 21, 2023 | 7.47 | 43 | -93.72% |
Oct 17, 2023 | 9.02 | 685 | -14.37% |
Sep 21, 2023 | 13.15 | 800 | +1381.48% |
Aug 14, 2023 | 18.91 | 54 | +10.20% |
Jul 19, 2023 | 22.20 | 49 | +96.00% |
Jun 29, 2023 | 25.40 | 25 | -94.23% |
May 25, 2023 | 31.51 | 433 | -88.62% |
Apr 24, 2023 | 32.11 | 3.81K | +253.95% |
Mar 29, 2023 | 31.39 | 1.07K | +198.61% |
Feb 28, 2023 | 35.10 | 360 | -65.78% |
Jan 31, 2023 | 32.82 | 1.05K | n/a |